Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating immune complexes in patients with progressive systemic sclerosis.

K Siminovitch, M Klein, W Pruzanski

    Arthritis and Rheumatism
    |October 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Genome-wide analysis in 756,646 individuals provides first genetic evidence that <i>ACE2</i> expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease.

    medRxiv : the preprint server for health sciences·2021
    Same author

    Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients.

    Annals of the rheumatic diseases·2009
    Same author

    Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    Arthritis and rheumatism·2008
    Same author

    Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.

    Annals of the rheumatic diseases·2008
    Same author

    Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis.

    Annals of the rheumatic diseases·2008
    Same author

    Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.

    Annals of the rheumatic diseases·2008

    Immune complexes are rarely found in progressive systemic sclerosis but may contribute to lung damage. Further research is needed to understand their role in this autoimmune disease.

    Area of Science:

    • Immunology
    • Rheumatology
    • Autoimmune Diseases

    Background:

    • Progressive systemic sclerosis (PSS) is a complex autoimmune disease.
    • The role of immune complexes in PSS pathogenesis remains unclear.

    Purpose of the Study:

    • To investigate the presence and significance of immune complexes in patients with PSS.
    • To explore the association between immune complexes and clinical manifestations, particularly lung involvement.

    Main Methods:

    • Studied 41 patients with PSS for immune complexes using C1q binding and conglutinin assays.
    • Assessed complement activation and autoantibodies.
    • Compared clinical and serologic features between patients with and without immune complexes.

    Main Results:

    Related Experiment Videos

    • Immune complexes were detected in only 15% of patients.
    • Complement activation was observed in a similar proportion of patients.
    • Lung involvement was significantly more frequent in patients with immune complexes.

    Conclusions:

    • Complement-fixing immune complexes are infrequently detected in PSS.
    • These complexes may play a role in the development of lung lesions in PSS.
    • Further investigation into the immunopathogenesis of PSS is warranted.